SCIASCIA THOMAS (Chief Medical Officer) sold 1.2% of their position (2.63K shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2025ACC: 0000950170-25-045295
Officer10% Owner· Chief Medical Officer
Since May 2019
-2.63K
Net shares
Net seller
$17.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.63K acquired · 5.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.63K
Price / share
$1.43
Trade value
$3.76K
% of position
1.2%
3/25/2025
221.37K→224K
Common Stock
Direct
Shares
−2.63K
Price / share
$6.60
Trade value
$17.36K
% of position
1.2%
3/25/2025
224K→221.37K
Total
Net shares
+0.00
Net value
-$13.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/25/2025 | M · Option Exercise | +2.63K | $1.43 | $3.76K | 1.2% | 221.37K | 224K |
| Common Stock Direct | 3/25/2025 | S · Sale | −2.63K | $6.60 | $17.36K | 1.2% | 224K | 221.37K |
| Total | +0.00 | -$13.60K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
2.63K shares
Shares
−2.63K
Strike price
1.43
Held after
0.00
Exercisable
—
3/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2.63K shares | 3/25/2025 | M · Option Exercise | −2.63K | 1.43 | — | 0.00 |